Geras Solutions believes that Paper-Pen based cognitive assessments are subjective, slow and out of date.
Additionally, the threshold to obtain a dementia diagnosis is often quite high and often associated with long waiting times that contribute to many never obtaining care. Lastly, due to global specialist shortages, not all patients have access to follow-up support.
Because of this, we were inspired to develop an AI-based Medical Device, and ecosystem of digital solutions focused on dementia support via an easy-to-use mobile health tool. Geras Solutions aims to help throughout the entire dementia lifecycle by using AI to simplify and streamline testing that can often be time-consuming while processing and organising that data in such a way that it helps provide a scientific and clinically-tested assessment that is accurate.
Our tests are based on widely acknowledged cognitive assessment methods and have been developed and clinically tested with Karolinska University Hospital Memory Clinic in Stockholm, Sweden. By testing on SCI, MCI and patients diagnosed with dementia we can establish appropriate cut off values and ensure that our digital profiles are linked to clinical data collected (CSF, MRI, Blood samples, etc) and able to be used for computational comparison. The results obtained from the various modules within Geras Solutions allow us to generate a very detailed and comprehensive cognitive profile quickly.
We offer a comprehensive range of cutting-edge health solutions within our CE Marked app that includes:
A Digital screening tool consisting of self-administered tests and forms that objectively measure cognition via thousands of digital data points.
Simplified and direct follow-up support for patients, clinical practitioners and caregivers.
Empowering users to allign with Risk Reduction methods, based on FINGER, to prevent or delay cognitive decline through lifestyle changes. In addition to positive effects on cognition, significant positive effects related to other chronic diseases were seen by introducing lifestyle interventions and modifications, over time, and encouraging individuals to track and improve their own health.
Rapid access to appropriate screening tools can help optimize patient flows by ensuring appropriate focus on time-sensitive patients, while being able to monitor the cognitive progression of others continually.
Normative data obtained during clinical studies allows us to compare patient data and detect cognitive abnormalities. This simplified and objective process will save much time during the collection and analysis process for all doctors, neurospecialists, psychologists and occupational therapists.
All healthy patients will receive a baseline profile. This profile can function as an essential comparison should the patient develop symptoms of cognitive decline. Specialists can then remotely monitor patients’ cognitive progression over time and ensure swift support if cognitive changes are detected in the future.
Our tests evaluate the following cognitive functions:
One screening takes approximately 30-45 minutes to complete.
Orientation in time